Kailera Therapeutics Inc.

KLRA | NASDAQ

Price Alert Chart Builder DCF Calculator

$12.86

-$0.55 (-4.10%)

At close: Oct 30, 2026, 4:00 PM ET

$12.86

$0.00 (0.00%)

After-hours: Oct 30, 2026, 7:30 PM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Market Data

Market Cap $1.67B

Enterprise Value $760.69M

Beta 0.50

Average Volume 983.42K

Shares Outstanding (Diluted) 102.23M

Shares Change YoY N/A

Institutional Ownership 99.40%

Exchange NASDAQ

ISIN US4829311020

Price Performance

Price Change 1M 12.6%

Price Change 3M -24.1%

Price Change 6M -48.9%

Price Change YTD N/A

Price Change 1Y N/A

Price Change 3Y N/A

Price Change 5Y N/A

1M CAGR (ann.) 0.2%

1Y CAGR (ann.) N/A

5Y CAGR (ann.) N/A

All-Time CAGR -73.0%

Valuation

PE Ratio -7.31

Forward PE N/A

PEG Ratio -0.07

Forward PEG 0.07

PS Ratio N/A

Forward PS N/A

PB Ratio 1.49

P/FCF Ratio -11.43

P/Adj. FCF Ratio -10.54

P/OCF Ratio -8.99

EV/Sales N/A

EV/EBIT -3.88

EV/EBITDA -3.88

EV/FCF -5.22

Earnings Yield -13.7%

FCF Yield -8.8%

Adj. FCF Yield -9.5%

Financial Health

Net Cash $915.69M

Total Debt $10.22M

Cash & Short-Term Investments $916.74M

Total Assets $1.21B

Current Ratio 11.11

Quick Ratio 11.11

Debt / Equity Ratio 0.01

Debt / EBITDA -0.05

Debt / FCF -0.07

OCF / Debt -14.28

Interest Coverage 0.00

Altman Z-Score 10.42

Piotroski F-Score 1

Margins & Profitability

Gross Profit Margin 0.0%

Operating Profit Margin 0.0%

EBITDA Margin 0.0%

Net Profit Margin 0.0%

FCF Margin N/A

Adj. FCF Margin N/A

SBC / Revenue 0.0%

SBC Impact (per share) -8.4%

Returns

Return on Assets -15.7%

Return on Equity -55.4%

Return on Invested Capital -18.3%

Return on Capital Employed -18.3%

Return on Tangible Assets -15.7%

Analyst Forecasts

Analyst Rating Hold

Analyst Count 0

EPS Growth Next 3Y -40.0%

Revenue Growth Next 3Y N/A

Earnings Date Nov 4, 2026

EPS Estimate (next Q) -$1.01

EPS Growth Est (next Q) N/A

Revenue Est (next Q) N/A

Revenue Growth Est (next Q) N/A

Fair Value Estimates

Graham Number N/A

Graham Upside N/A

Lynch Fair Value N/A

Lynch Upside N/A

Price Target $42.00

Price Target Upside 226.6%

Cash Flow

Operating Cash Flow $-145.84M

Free Cash Flow $-145.84M

Adj. Free Cash Flow $-158.12M

FCF Per Share -$1.43

OCF Per Share -$1.43

OCF/S Ratio 0.0%

Income Statement

Revenue $0

Gross Profit $0

Operating Income $-206.03M

EBITDA $-195.87M

Net Income $-190.17M

EPS (Diluted) -$1.76

Revenue / Employee N/A

Profit / Employee $-1.31M

Employees 145